H-CYTE, INC. INVESTORS’ RIGHTS AGREEMENT Dated as of November 15, 2019 INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This INVESTORS’ RIGHTS AGREEMENT is made and entered into as of the 15th day of November, 2019, by and among H-CYTE, INC., a Nevada corporation (the “Company”) and each of the investors listed on Schedule I hereto (the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Florida
This Securities Purchase Agreement (this “Agreement”) is dated as of November 15, 2019, by and among H-Cyte, Inc., a Nevada corporation (the “Company”) and the purchasers identified on the signature pages hereto (including any successors and assigns, the “Purchaser(s)”).
H-CYTE, INC. AMENDED AND RESTATED VOTING AGREEMENT as of November 15, 2019 AMENDED AND RESTATED VOTING AGREEMENTVoting Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This Amended and Restated Voting Agreement (this “Agreement”) is entered into as of November 15, 2019 by and among (i) H-Cyte, Inc., a Nevada corporation (the “Company”), (ii) each holder of the Company’s Series B Preferred Stock (“Series B Preferred Stock”) listed on Schedule I (the “Series B Investors”), (iii) each holder of the Company’s Series D Preferred Stock (“Series D Preferred Stock”) listed on Schedule II (the “Series D Investors” and, together with the Series Series B Investors, and any subsequent investors, or transferees, who become parties hereto as “Investors” pursuant to Sections 6.1(a) or 6.2 below, the “Investors”) and (vi) those certain stockholders of the Company listed on Schedule III (together with any subsequent stockholders, or any transferees, who become parties hereto as “Key Holders” pursuant to Sections 6.1(b) or 6.2 below, the “Key Holders,” and together collectively with the Investors, the “Stockholders”).
H-CYTE, INC. RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT as of November 15, 2019 RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTSale Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This Right of First Refusal and Co-Sale Agreement (this “Agreement”) is entered into as of November 15, 2019 by and among (i) H-Cyte, Inc., a Nevada corporation (the “Company”), (ii) the Investors listed on Schedule I (the “Investors”), and (iii) the Key Holders listed on Schedule II.
SERVICES AGREEMENTServices Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus
This Services Agreement (this “Agreement”) is entered into this 18th_ day of November , 2019 (the “Effective Date”), between and among H-Cyte, Inc., a Nevada corporation (“H-Cyte”), and Rion, LLC, a Minnesota limited liability company (“Rion”).
